• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

276.5500 USD 2.4300 0.89%

As of 20:10:00 ET on 08/29/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 274.2000 High - Low: 276.6299 - 273.8500 Primary Exchange: NASDAQ GM
Volume: 603,318 52-Week Range: 191.2903 - 276.7100 Beta vs XNBI: 1.0004

ETF Chart for IBB

No chart data available.
  • IBB:US 276.5200
  • 1D
  • 1M
  • 1Y
274.1200
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-08-29) 276.5600
Assets (M) (on 2014-08-29) 5,531.2220
Shares out (M) 20.00
Market Cap (M) 5,531.00
% Premium -0.00
Average 52-Week % Premium 0.0012
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.14%

Performance for IBB

1-Month +10.25% 1-Year +42.96%
3-Month +15.60% 3-Year +42.56%
Year To Date +21.98% 5-Year +29.06%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 08/28/2014
Name Position Value % of Total
Gilead Sciences Inc 4,784,352 514,365,684 9.439%
Celgene Corp 5,077,918 480,878,835 8.825%
Amgen Inc 3,349,756 464,577,660 8.526%
Biogen Idec Inc 1,216,570 415,142,347 7.618%
Alexion Pharmaceuticals Inc 2,135,467 359,420,451 6.596%
Vertex Pharmaceuticals Inc 2,688,467 249,489,738 4.578%
Illumina Inc 1,227,613 219,840,936 4.034%
Regeneron Pharmaceuticals Inc 632,881 219,559,077 4.029%
Mylan Inc/PA 3,897,841 187,603,087 3.443%
BioMarin Pharmaceutical Inc 1,696,938 118,140,824 2.168%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil